Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 308

1.

Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial.

Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenko AN, Kosiborod MN, McGuire DK, Harrington RA; THEMIS Steering Committee and Investigators.

Lancet. 2019 Sep 28;394(10204):1169-1180. doi: 10.1016/S0140-6736(19)31887-2. Epub 2019 Sep 1.

2.

Effects of Serelaxin in Patients with Acute Heart Failure.

Metra M, Teerlink JR, Cotter G, Davison BA, Felker GM, Filippatos G, Greenberg BH, Pang PS, Ponikowski P, Voors AA, Adams KF, Anker SD, Arias-Mendoza A, Avendaño P, Bacal F, Böhm M, Bortman G, Cleland JGF, Cohen-Solal A, Crespo-Leiro MG, Dorobantu M, Echeverría LE, Ferrari R, Goland S, Goncalvesová E, Goudev A, Køber L, Lema-Osores J, Levy PD, McDonald K, Manga P, Merkely B, Mueller C, Pieske B, Silva-Cardoso J, Špinar J, Squire I, Stępińska J, Van Mieghem W, von Lewinski D, Wikström G, Yilmaz MB, Hagner N, Holbro T, Hua TA, Sabarwal SV, Severin T, Szecsödy P, Gimpelewicz C; RELAX-AHF-2 Committees Investigators.

N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.

PMID:
31433919
3.

Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation.

Lopes RD, Heizer G, Aronson R, Vora AN, Massaro T, Mehran R, Goodman SG, Windecker S, Darius H, Li J, Averkov O, Bahit MC, Berwanger O, Budaj A, Hijazi Z, Parkhomenko A, Sinnaeve P, Storey RF, Thiele H, Vinereanu D, Granger CB, Alexander JH; AUGUSTUS Investigators.

N Engl J Med. 2019 Apr 18;380(16):1509-1524. doi: 10.1056/NEJMoa1817083. Epub 2019 Mar 17.

4.

Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study.

Bhatt DL, Fox K, Harrington RA, Leiter LA, Mehta SR, Simon T, Andersson M, Himmelmann A, Ridderstråle W, Held C, Steg PG; THEMIS Steering Committee.

Clin Cardiol. 2019 May;42(5):498-505. doi: 10.1002/clc.23164. Epub 2019 Apr 9.

5.

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.

Wiviott SD, Raz I, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Silverman MG, Zelniker TA, Kuder JF, Murphy SA, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Ruff CT, Gause-Nilsson IAM, Fredriksson M, Johansson PA, Langkilde AM, Sabatine MS; DECLARE–TIMI 58 Investigators.

N Engl J Med. 2019 Jan 24;380(4):347-357. doi: 10.1056/NEJMoa1812389. Epub 2018 Nov 10.

PMID:
30415602
6.

Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial.

Bohula EA, Scirica BM, Inzucchi SE, McGuire DK, Keech AC, Smith SR, Kanevsky E, Murphy SA, Leiter LA, Dwyer JP, Corbalan R, Hamm C, Kaplan L, Nicolau JC, Ophuis TO, Ray KK, Ruda M, Spinar J, Patel T, Miao W, Perdomo C, Francis B, Dhadda S, Bonaca MP, Ruff CT, Sabatine MS, Wiviott SD; CAMELLIA-TIMI 61 Steering Committee Investigators.

Lancet. 2018 Nov 24;392(10161):2269-2279. doi: 10.1016/S0140-6736(18)32328-6. Epub 2018 Oct 4.

7.

Tuning the Nanoscale Properties of Phosphorylated Cellulose Nanofibril-Based Thin Films To Achieve Highly Fire-Protecting Coatings for Flammable Solid Materials.

Ghanadpour M, Carosio F, Ruda MC, Wågberg L.

ACS Appl Mater Interfaces. 2018 Sep 26;10(38):32543-32555. doi: 10.1021/acsami.8b10309. Epub 2018 Sep 11.

PMID:
30148604
8.

Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients.

Bohula EA, Wiviott SD, McGuire DK, Inzucchi SE, Kuder J, Im K, Fanola CL, Qamar A, Brown C, Budaj A, Garcia-Castillo A, Gupta M, Leiter LA, Weissman NJ, White HD, Patel T, Francis B, Miao W, Perdomo C, Dhadda S, Bonaca MP, Ruff CT, Keech AC, Smith SR, Sabatine MS, Scirica BM; CAMELLIA–TIMI 61 Steering Committee and Investigators.

N Engl J Med. 2018 Sep 20;379(12):1107-1117. doi: 10.1056/NEJMoa1808721. Epub 2018 Aug 26.

9.

[Diagnosis and Treatment of Patients With Non-ST-Segment Elevation Acute Coronary Syndrome. Part 2].

YAvelov IS, Ruda MY, Averkov OV, Panchenko EP.

Kardiologiia. 2017 Sep;57(9):83-96. Russian. No abstract available.

PMID:
29466228
10.

[Carotid Plaque Instability in Patients With Acute Coronary Syndrome as Assessed by Ultrasound Duplex Scanning].

Pogorelova OA, Tripoten MI, Guchaeva DA, Shahnovich RM, Ruda MY, Balakhonova TV.

Kardiologiia. 2017 Dec;57(12):5-15. Russian.

PMID:
29466206
11.

Multilocus Analysis of Genetic Susceptibility to Myocardial Infarction in Russians: Replication Study.

Kukava NG, Titov BV, Osmak GJ, Matveeva NA, Kulakova OG, Favorov AV, Shakhnovich RM, Ruda MY, Favorova OO.

Acta Naturae. 2017 Oct-Dec;9(4):74-83.

12.

Impact of 9p21.3 region and atherosclerosis-related genes' variants on long-term recurrent hard cardiac events after a myocardial infarction.

Osmak GJ, Titov BV, Matveeva NA, Bashinskaya VV, Shakhnovich RM, Sukhinina TS, Kukava NG, Ruda MY, Favorova OO.

Gene. 2018 Mar 20;647:283-288. doi: 10.1016/j.gene.2018.01.036. Epub 2018 Jan 10.

PMID:
29331485
13.

[Diagnosis and Treatment of Patients With Non-STSegment Elevation Acute Coronary Syndrome. Part 3].

YAvelov IS, Ruda MY, Averkov OV, Panchenko EP.

Kardiologiia. 2017 Oct;57(10):98-104. Russian. No abstract available.

PMID:
29276936
14.

[Myocardial Hypoenhancement on Multidetector Computed Tomography in Patients With Non-ST Elevation Acute Coronary Syndrome].

Ruda MY, Barysheva NA, Merkulova IN, Shabanova MS, Shariya MA, Gaman SA, Sukhinina TS, Veselova TN.

Kardiologiia. 2017 Oct;57(10):5-11. Russian.

PMID:
29276924
15.

[Diagnosis and Treatment of Patients With Non-STSegment Elevation Acute Coronary Syndrome. Part 4].

YAvelov IS, Ruda MY, Averkov OV, Panchenko EP.

Kardiologiia. 2017 Nov;57(11):94-104. Russian. No abstract available.

PMID:
29276923
16.

Proportional pulse pressure relates to cardiac index in stabilized acute heart failure patients.

Petrie CJ, Ponikowski P, Metra M, Mitrovic V, Ruda M, Fernandez A, Vishnevsky A, Cotter G, Milo O, Laessing U, Zhang Y, Dahlke M, Zymlinski R, Voors AA.

Clin Exp Hypertens. 2018;40(7):637-643. doi: 10.1080/10641963.2017.1416121. Epub 2017 Dec 21.

PMID:
29265934
17.

Genetic risk factors for myocardial infarction more clearly manifest for early age of first onset.

Titov BV, Osmak GJ, Matveeva NA, Kukava NG, Shakhnovich RM, Favorov AV, Ruda MY, Favorova OO.

Mol Biol Rep. 2017 Aug;44(4):315-321. doi: 10.1007/s11033-017-4112-5. Epub 2017 Jul 6.

PMID:
28685248
18.

Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in Russia: an observational study (EPICOR-RUS study).

Ruda MY, Averkov OV, Khomitskaya YV.

Curr Med Res Opin. 2017 Jul;33(7):1269-1276. doi: 10.1080/03007995.2017.1313214. Epub 2017 Apr 19.

PMID:
28420281
19.

[Combined Effect of Genetic Factors, Age, and Smoking on the Risk of Developing Myocardial Infarction].

Osmak G J, Matveeva NA, Titov BV, Nasibullin TR, Mustafina OE, Shakhnovich RM, Kukava NG, Ruda MY, Favorova OO.

Kardiologiia. 2016 Dec;56(12):5-10. Russian.

PMID:
28290798
20.

Platelet subpopulation bearing leukocyte specific antigen and tissue factor.

Gabbasov ZA, Saburova OS, Antonova OA, Golubeva NV, Khaspekova SG, Shustova ON, Zyuryaev IT, Ruda MY, Mazurov AV.

Dokl Biochem Biophys. 2016 Nov;471(1):431-434. doi: 10.1134/S1607672916060156. Epub 2017 Jan 6.

PMID:
28058691

Supplemental Content

Loading ...
Support Center